期刊文献+

CD109对人宫颈鳞状细胞癌临床病理表现的影响 被引量:1

Influence of CD109 on the clinical pathological manifestations of human cervix squamous cell carcinoma
下载PDF
导出
摘要 目的探讨CD109表达与人宫颈鳞状细胞癌临床病理表现之间的关系。方法选取天津医科大学附属肿瘤医院正常宫颈组织14例、宫颈上皮内瘤变3级(CIN3)组织14例、宫颈浸润性鳞状细胞癌及其淋巴结转移瘤组织12例。采用免疫组化法检测不同病理学分级宫颈组织中CD109和Ki-67的表达,并采用Western blotting进一步验证。采用Spearman等级相关分析CD109和Ki-67表达的相关性。结果 CD109的表达随病变进展逐渐增强,在宫颈浸润性鳞癌及其淋巴结转移瘤组织中的表达明显高于正常宫颈和CIN3组织中的表达(P<0.05)。Ki-67的表达随着宫颈病变的进展呈现增高趋势,各组间差异具有统计学意义(P<0.05)。CD109与Ki-67的表达阳性率呈正相关(r=0.953,P<0.01)。结论 CD109与宫颈鳞癌细胞增殖相关,且在宫颈鳞状细胞癌的发生、发展及浸润、转移过程中起重要作用。 Objective To explore the relationship between the expression of CD109 and the clinical pathological manifestations of human cervix squamous cell carcinoma. Methods Fourteen pieces of normal cervix tissue, 14 pieces of cervical intraepithelial neoplasia 3 (CIN3) tissue, 12 pieces of primary invasive cervix squamous carcinoma tissue and metastatic lymph-node tissue of cervix squamous cell carcinoma in Cancer Hospital of Tianjin Medical University were collected to conduct immunohistochemical staining for detecting the expression of CD 109. The results were further confirmed by Western blotting. The expression of Ki-67 in the aforesaid samples was detected by immunohistochemical staining and the relationship between CD109 and Ki-67 was analyzed. Results The CD109 expression gradually increased with tumor progression. The expression of CD109 were significantly higher in cervix squamous cell carcinoma tissue and metastatic lymph-node tissue than in normal cervix tissue and CIN3 tissue (P〈0.05). The Ki-67 expression also increased with tumor progression. The differences in Ki-67 expression among the four groups were statistically significant (P〈0.05). CD109 expression was positively correlated with the expression of Ki-67(r=0.gs3, P〈0.01). Conclusions CD109 seems to correlate with the proliferation of cervix squamous carcinoma cell and may play an important role in the development, progression, invasion and metastasis of cervix squamous cell carcinoma.
出处 《解放军医学杂志》 CAS CSCD 北大核心 2012年第10期966-969,共4页 Medical Journal of Chinese People's Liberation Army
基金 国家自然科学基金面上项目(30700983) 武警医学院面上项目(WY200805)~~
关键词 宫颈肿瘤 病理学 临床 uterine cervical neoplasms pathology, clinical
  • 相关文献

参考文献16

  • 1Haregewoin A, Solomon K, Horn KC, ct al. Cellular expression ofa GPI-linked T cell activation protein[J]. Cell Immunol, 1994, 156(2): 357-370.
  • 2Lin M, Sutherland DR, Horsfall W, et al. Cell surface antigen CD109 is a novel member of the cx 2 macroglobulin/C3p C4, C5 family of thioestercontaining proteins[J]. Blood, 2002, 99(5): 1683-1691.
  • 3Hagiwara S, Murakumo Y, Sato T, et al. Up-regulation of CD 109 expression is associated with carcinogenesis of the squamous epithelium of the oral cavity [J]. Cancer Sci, 2008, 99 ( 10 ): 1916- 1923.
  • 4周瑾,刘伟,桂俊豪,冯桂萍,王瑞,刘鸿春,卢静.新疆维、汉族宫颈鳞癌病变中HPV16 E6基因变异分析[J].解放军医学杂志,2011,36(12):1273-1276. 被引量:8
  • 5Murray LJ, Bruno E, Uchida N, et al. CD109 is expressed on a subpopulation of CD34+ cells enriched in hematopoietic stem and progenitor cells [J]. Exp Hematol, 1999, 27(8): 1282-1294.
  • 6Giesert C, Marxer A, Sutherland DR, et al. Antibody W7C5 defines a CD109 epitope expressed on CD34 and CD34 hematopoietic and mesenchymal stem cell subsets [J]. Ann NY Acad Sci, 2003, 996(5): 227-230.
  • 7Hasegawa M, Hagiwara S, Sato T, et al. CD109, a new marker for myoepithelial cells of mammary, salivary, and lacrimal glands and prostate basal cells[J]. Pathol Int, 2007, 57(5): 245-250.
  • 8Sato T, Murakumo Y, Hagiwara S, et al. High-level expression of CD109 is frequently detected in lung squamous cell carcinomas[J]. Pathol Int, 2007, 57(11): 719-724.
  • 9Jarvinen AK, Autio R, Kilpinen S, et al. High-resolution copy number and gene expression microarray analyses of head and neck squamous cell carcinoma cell lines of tongue and larynx[J]. Genes Chromosomes Cancer, 2008, 47(6): 500-509.
  • 10Hasegawa M, Moritani S, Murakumo Y, et al. CD109 expression in basal-like breast carcinoma[J]. Pathol Int, 2008, 58(5): 288- 294.

二级参考文献26

  • 1马正海,张富春,梅新娣,马彩玲,刘开江.新疆维吾尔族妇女宫颈癌组织中HPV16型E6基因突变分析[J].癌症,2004,23(9):1016-1020. 被引量:17
  • 2李庭芳,古力娜.库尔班,古丽沙热,贺国丽,王涛,海日古丽,王振华.新疆伽师县夏普桃勒乡妇女子宫颈癌防治研究[J].新疆医学院学报,1996,19(3):199-203. 被引量:64
  • 3杨英捷,赵健,廖秦平.北京地区人乳头瘤病毒16型感染及其E6/E7基因变异与宫颈病变的相关性研究[J].中华实验和临床病毒学杂志,2007,21(1):32-34. 被引量:15
  • 4Nair P, Jayaprakash PG, Nair MK, et at. Telomerase, p53 and hu man papillomavirus infection in the uterine cervix[J]. Acta Oncol, 2000, 39(1): 65-70.
  • 5Gewin L, Galloway DA. E box-dependent activmion of telomerase by human papillomavirus type 16 E6 does not require induction of c-myc [J]. J Virol, 2001, 75(15): 7198 -7201.
  • 6Nakamura TM, Morin GB, Chapman KB, et al. Telomerase catalytic subunit homologs from fission yeast and human [J]. Science, 1997, 277(5328) : 955-959.
  • 7zur Hausen H. Papillomaviruses causing cancer: evasion from host cell control in early events in carcinogenesis[J].J Natl cancer Inst, 2000, 92(9): 690- 698.
  • 8Crook T, Tidy JA, Vousden KH. Degradation of p53 can be targeted by HPV E6 sequences distinct from those required for p53 binding and trans-activation [J]. Cell, 1991, 67(3): 547-556.
  • 9Foster SA, Demers GW, Etscheid BG, et al. The ability of human papillomavirus E6 proteins to target p53 for degradation in vivo correlates with their ability to abrogate actinomycin D-induced growth arrest[J]. J Virol, 1994, 68(9): 5698-5705.
  • 10Gao L, Chain B, Sinclair C, et al. Immune response to human papil lomavirus type 16 E6 gene in a live vaccinia vector[J]. J Gen Virol, 1994, 75(Pt 1):157-164.

共引文献7

同被引文献6

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部